Return to Web Version
Sigma-Aldrich
Life Science > Cell Biology > Cancer Research > Learning Center > Carcinogen Selector > Endocrine System > Harderian Gland
Cancer Research

Harderian Gland

Harderian Gland
Thyroid Gland
Ear/Zymbal's Gland
Liver
Mammary Gland
Testes
Clitoral/Preputial Gland
Pancreas
Ovary
Adrenal Gland
Pituitary Gland

Sigma Logo Carcinogen Selector Header

The Carcinogen Selector gives researchers the ability to select carcinogens by the mouse organs that they promote cancer in. The tool includes over 750 carcinogens that target 35 specific organs across 9 biological systems.

Step 1:     Select a biological system.     Step 2:     Use the mouse model to select an organ.     Step 3:     Review the organ specific carcinogen table to identify products.


Digestive System
Endocrine System
Hematopoietic System
Integumentary System
Reproductive System
Respiratory System
Skeletal System
Urinary System
Vascular System
Mouse

Endocrine System: Harderian Gland
Product # Description Product # Description
110124 1,2,3-Trichloropropane 295035 1,3-Butadiene
301930 2,2-Bis(bromomethyl)-1,3-propanediol 281972 3-Chloro-2-methyl-1-propene
516805 4,4.-Oxydianiline 110213 Acrylonitrile
401765 Benzene B3383 Benzidine dihydrochloride
45365 Captafol 861145 Chloroprene
C3886 Crystal Violet 675636 Cupferron
387614 Ethylene oxide G5809 Glycidol
464953 Isoprene 245801 N-(Hydroxymethyl)acrylamide SOLUTION
360554 Nitromethane 371696 Tetrachloroethylene



your favorite gene search

powered by ingenuity

Service & Support
Ordering
Corporate

©2011 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA, SAFC, SIGMA-ALDRICH, ALDRICH, and SUPELCO are trademarks of Sigma-Aldrich Co. LLC, registered in the US and other countries. FLUKA is a trademark of Sigma-Aldrich GmbH, registered in the US and other countries. Sigma brand products are sold through Sigma-Aldrich, Inc. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Site Use Terms | Privacy

  • YouTube
  • Twitter
  • LinkedIN
  • Facebook